# Saltagen Ventures

> Saltagen Ventures is a VC fund backing Health Care. See 16 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Central, Hong Kong
- Total investments: 16
- Last investment: Jun 2026
- Lead investor: 25%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/saltagen-ventures/
- X (Twitter): https://twitter.com/Saltagen
- Website: http://saltagen.com

Saltagen Ventures is an early-stage venture capital firm that invests in science and technology-based startups.Its investment strategy focuses on the verticals of edtech, biomedical technology, AI and machine learning, and media technology. They search for startups that have strong defensibility and patentable technology and empowers them to growtheir business and develop efficiencies.The firm was founded in 2017 in Central, Hong Kong by Joseph Fung.

## Contacts

5 contacts available for Saltagen Ventures. Shizune tracks 4 team members at Saltagen Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/saltagen-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 6 | 38% |
| Artificial Intelligence | 5 | 31% |
| Software | 3 | 19% |
| Biotechnology | 3 | 19% |
| Medical Device | 3 | 19% |

34 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 9 | 56% |
| Pre-Seed | 2 | 13% |
| Series A | 2 | 13% |
| Series B | 1 | 6% |
| Venture - Series Unknown | 1 | 6% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 6 | 38% |
| Hong Kong | 3 | 19% |
| United States | 3 | 19% |
| Denmark | 1 | 6% |
| Australia | 1 | 6% |

6 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Simon Lai | Chief Operating Officer | 0 | — |
| Yina Chan | Principal | 0 | — |
| Jason Chiu | Investment Committee Member | 1 | https://shizune.co/investors/profile/jason-chiu |
| Joseph Fung | Managing Partner | 2 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Spot Biosystems | Spot BioSystems is a bioengineering firm that specializes in personalized cancer treatments. The company's headquarters are in Palo Alto, California. | $40M | Venture - Series Unknown | Jun 17, 2026 |  |
| PulseMedica | PulseMedica, an Edmonton-based medical device startup, is developing an ophthalmic medical device platform for non-invasive, automated image-guided laser treatment enabled by 3D computer vision, real-time tracking, and femtosecond laser technology. PulseMedica is laser-focused on improving the quality of life for millions of people by buildingrevolutionary technology to image and treat vitreoretinal disease. PulseMedica’s short-term vision is to become the global expert in non-invasive, safe, effective screening and treatment of eye floaters, with the ultimate vision of becoming the global standard for screening and treating vitreoretinal disease. | $8.7M | Seed | May 29, 2024 |  |
| Fano Labs | Fano Labs provides automatic language detection and multilingual speech recognition, with capabilities for mixed-language transcription. The company’s proprietary automatic speech recognition models are designed for enterprise environments and focus on accuracy in complex, real-world conversations. Fano Labs enables organizations to analyze callrecordings, live chats, and emails to extract insights related to sales performance, compliance monitoring, operational workflows, and customer sentiment. |  | Series B | May 02, 2024 |  |
| Beatdapp | Beatdapp offers a tracking system that authenticates, verifies, and validates media streamed in real-time.The service reduces the tracking discrepancies between Digital Service Providers (DSPs) and rights holders, increasing royalty revenue for rights holders while limiting legal exposure to royalty lawsuits for DSPs. Think of it like a PWC formusic play count. | $17M | Series A | Jan 19, 2024 |  |
| CHILD Health Imprints | Child Health Imprints is engaged in the development and application of cutting edge informational and computational technologies including IoT, artificial intelligence and predictive analytics to the practice of medicine in neonatal intensive care units across the world with the objective of making early diagnosis of critical diseases and improvingoverall quality of healthcare which is being provided to neonates. | $2.5M | Seed | Jan 09, 2023 |  |
| Sympatic | Sympatic helps owners and users of sensitive data cooperate to extract value without ever risking their data or giving away their intellectual property. We do this by creating temporary, secure compute bastions in their cloud where algorithms meet data. We let them do this safely and repeatedly, even if they have no idea how to do complex cloudDevOps. |  | Pre-Seed | Aug 04, 2022 |  |
| Oncoustics AI | Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers. | $5M | Seed | Jul 21, 2022 |  |
| Evolved.Bio | CaroMeats grows healthy, delicious meat directly from animal cells. No environmental damage is caused. No animals are harmed. | $2M | Seed | May 19, 2022 |  |
| Modl.ai | Modl.ai delivers game technology that accelerates game development and enhances player engagement around the world. | $1.7M | Seed | Feb 03, 2020 |  |
| Juno Diagnostics | Juno Diagnostics is a health technology company democratizing access to high-value genetic information. The company is developing simple, cost-effective devices that enable point-of-need genetic testing. It was founded in 2017 and is based in San Diego, California. |  | Seed | Jan 01, 2019 |  |

10 of 16 investments shown.

## Co-investors
- [Creative Ventures](https://shizune.co/investors/profile/creative-ventures) — VC Fund, 2 deals together
- [Pool Global Partners](https://shizune.co/investors/profile/pool-global-partners) — VC Fund, 2 deals together
- [ScaleGood Fund LP (powered by TELUS)](https://shizune.co/investors/profile/scalegood-fund) — VC Fund, 2 deals together
- [UCeed](https://shizune.co/investors/profile/uceed) — VC Fund, 2 deals together
- [Velocity](https://shizune.co/investors/profile/velocity-4) — VC Fund, 2 deals together
- [Accelerate Fund](https://shizune.co/investors/profile/accelerate-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Saltagen Ventures invest in?

Saltagen Ventures invests primarily in Health Care, Artificial Intelligence and Software startups, most often at Seed and Pre-Seed stage. Most of the 16 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Saltagen Ventures?

Public channels for Saltagen Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Saltagen Ventures?

The team at Saltagen Ventures includes Simon Lai (Chief Operating Officer), Yina Chan (Principal) and Jason Chiu (Investment Committee Member). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co